Dow Down1.40% Nasdaq Down1.59%

Echo Therapeutics, Inc. (ECTE)

-NasdaqCM
0.78 Down 0.06(6.90%) Oct 1, 3:59PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 28   5   447  
Cost of Revenue -   -   -  
Gross Profit 28   5   447  
Operating Expenses
Research Development11,299  8,671  3,796  
Selling General and Administrative8,365  6,374  4,906  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (19,636) (15,040) (8,255)
Income from Continuing Operations
Total Other Income/Expenses Net4,469  3,213  (1,761)
Earnings Before Interest And Taxes(15,167)(11,827)(10,014)
Interest Expense3,900  505  14  
Income Before Tax(19,067)(12,332)(10,028)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(19,067)(12,332)(10,030)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (19,067) (12,332) (10,030)
Preferred Stock And Other Adjustments(371) -  (6,693)
Net Income Applicable To Common Shares (19,439) (12,332) (16,722)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.